戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 ial aerosol-generating events (eg, coughing, sneezing).
2 ible for eliciting the ciliary response to a sneeze.
3 u of other bacteria/m3/min were released per sneeze.
4 vide a robust tether to withstand coughs and sneezes.
5 roduced via breathing, talking, coughing, or sneezing.
6 y reduced rhinorrhea, nasal obstruction, and sneezing.
7  were nasal stuffiness, nasal discharge, and sneezing.
8 infected ferrets during normal breathing and sneezing.
9 mptoms were nasal stuffiness, discharge, and sneezing.
10 nificant amount of S. aureus into the air by sneezing.
11  sessions with and without histamine-induced sneezing.
12 ng protective reflexes that include apnea or sneezing.
13 n of fever, muscle ache, scratchy throat, or sneezing.
14 plets (aerosols) via exhaling, coughing, and sneezing.
15 n B (NMB) peptide is essential for signaling sneezing.
16  CI 5.02-8.39), hair loss (3.99, 3.63-4.39), sneezing (2.77, 1.40-5.50), ejaculation difficulty (2.63
17 eloped to deliver a stimulation simulating a sneeze (55 mmHg for 50 ms) at 26 degrees C to the apical
18 is, including nasal itching, rhinorrhea, and sneezing, although most agents are not very effective in
19                        At the circuit level, sneeze and cough signals are transmitted and modulated b
20                 Nasal symptom scores (no. of sneezes and 0- to 5-point scores for severity of congest
21 l steroids led to a significant reduction in sneezes and eosinophil influx in nasal secretions withou
22 ol groups, except for a greater incidence of sneezing and application site reaction (99% mild or mode
23                                              Sneezing and coughing are primary symptoms of many respi
24                 It is generally assumed that sneezing and coughing involve common sensory receptors a
25                                  Relative to sneezing and coughing, non-symptomatic aerosol-producing
26 rotransmission/modulation mechanisms between sneezing and coughing, offering neuronal drug targets fo
27 ing an unforeseen sensory difference between sneezing and coughing.
28 presence of at least two symptoms: 'repeated sneezing and itchy nose', 'blocked nose for more than on
29 e, despite physical forces such as coughing, sneezing and mucociliary clearance.
30 rted improvements in smell and reductions in sneezing and nasal blockade.
31               The third year was better with sneezing and nasal discharge than the 2nd year, and the
32 peated BK challenges led to tachyphylaxis of sneezing and of neurally mediated serous glandular secre
33  presence of >/=1 rhinitis symptom (repeated sneezing and/or itchy nose, blocked nose for >1 h, or ru
34 eceptively well; he or she will have coryza, sneezing, and a mild cough.
35                                    Coughing, sneezing, and even talking emit respiratory droplets whi
36 ssociated with symptoms of nasal congestion, sneezing, and itching of the eyes, nose, and throat.
37  congestion, rhinorrhea, postnasal drainage, sneezing, and itching of the eyes, nose, and throat.
38 ere weight loss, ocular and nasal discharge, sneezing, and lethargy.
39  nerve evokes protective reflexes, including sneezing, apnea, and local neurogenic inflammation of th
40  character formed during speech, coughs, and sneezes are important.
41 ncreased cough, sore throat, runny nose, and sneezing are associated with the emergence of the Omicro
42 ng 3 feet closer, being exposed to coughs or sneezes as 3 to 4 ft closer, greeting with a hug as 7 ft
43 e provides specific relief of rhinorrhea and sneezing associated with common colds.
44 tion potentials in cVRG neurons and leads to sneezing behavior.
45 ically ~0.6-500 um in diameter (by coughing, sneezing, breathing, and talking).
46                                              Sneezing caused a 4.7-fold increase in the airborne disp
47  (36.8 versus 24.3 mm; p = 0.003), decreased sneeze clearability (20.6 versus 32 mm; p = 0.04), and i
48 s respiratory depression, nasal obstruction, sneezing, cough, and pain.
49 e throat, nasal discharge, nasal congestion, sneezing, cough, scratchy throat, hoarseness, muscle ach
50 treatment period; most were mild, nonocular (sneezing, cough, throat irritation, and instillation sit
51 ease in pressure in the upper airways during sneezing, coughing, or vomiting, which very rarely leads
52 sociated with barotrauma to the orbit due to sneezing, coughing, or vomiting.
53 s after being struck in his right eye by his sneezing Dachshund dog.
54  induced clinical symptoms such as coughing, sneezing, decreased activity, fever, and labored breathi
55 d point was defined after excluding the item sneezing due to its low ability to discriminate severity
56 of NMB-sensitive postsynaptic neurons in the sneeze-evoking region or deficiency in NMB receptor abol
57                                            A sneeze-evoking region was discovered in both cat and hum
58 y events relates to airspeed (speech, cough, sneeze), fluid properties of the saliva/mucus, and the f
59 stsynaptic to nasal sensory neurons mediates sneezing in this region.
60 o interrogate the molecular cascades driving sneeze-induced changes of CBF, pharmacologic manipulatio
61 significant immediate increases in symptoms, sneezes, ipsilateral nasal airway resistance, and ipsila
62 sues involved such symptoms include itching, sneezing, irritation, vasodilation, and reflex secretion
63 sons through exhaling, talking, coughing and sneezing is a major driver of SARS-CoV-2 transmission, w
64                                              Sneezing is a vital respiratory reflex frequently associ
65 ported blocked nose, 48% rhinorrhea, and 46% sneezing/itchy nose.
66 ction occurs but can include red itchy eyes, sneezing, nasal congestion, rhinorrhea, coughing, bronch
67 reatment reduced the severity of rhinorrhea, sneezing, nasal obstruction, sore throat, cough, and hea
68 nd group 3, rhinorrhea of -0.7 (SE, 0.3) and sneeze of -7.0 (SE, 1.5).
69 (SE, 0.3), rhinorrhea of -1.3 (SE, 0.3), and sneeze of -8.8 (SE, 1.5); group 2, itching of -0.6 (SE,
70 (SE, 0.3), rhinorrhea of -0.8 (SE, 0.3), and sneeze of -9.1 (SE, 1.5); and group 3, rhinorrhea of -0.
71 uate the effect of the mechanical force of a sneeze on sinonasal cilia function and determine the mol
72 t of colored dye that approximated a patient sneezing on a dimensionally accurate cardboard slit lamp
73 03), ipratropium was associated with reduced sneezing on study days 2 (20% difference; P = 0.03) and
74                               The effects of sneezing on the airborne dispersal of S. aureus and othe
75 rus exposure did not change the frequency of sneezing or airborne dispersal.
76 t two nasal symptoms: rhinorrhoea, blockage, sneezing or itching.
77  questionnaire: 484 (48.3%) had at least one sneezing, or a runny or blocked nose episodes without co
78 pharyngeal samples (shedding), coughing, and sneezing (P < .05).
79 (P = .004), 83% for daily summation operator sneezing (P = .001), 75% for daily summation operator wa
80 y delineates a peptidergic pathway mediating sneezing, providing molecular insights into the sneezing
81 , seasonal sensitivity, presence of a photic sneeze reflex).
82 ezing, providing molecular insights into the sneezing reflex arc.
83  or deficiency in NMB receptor abolished the sneezing reflex.
84  population (MrgprC11(+)MrgprA3(-)) mediates sneezing responses to a multitude of nasal irritants, al
85 nitis was defined as one or more episodes of sneezing, runny and/or blocked nose >2 weeks duration.
86                     Pollen-AR was defined as sneezing, runny, itchy or blocked nose; and itchy or wat
87 d the spread of S. aureus by 3.8-fold during sneezing sessions (P < .001).
88 r, and >/=2 of runny nose, nasal congestion, sneezing, sore throat, cough, swollen or tender neck gla
89      High-fidelity simulations of coughs and sneezes that serve as virtual experiments are presented,
90  the absence of symptoms such as coughing or sneezing, the importance of speech-generated aerosol in
91 hniques, we mimic the effect of coughing and sneezing, thereby testing the force stability of SARS-Co
92 s positive accompanied with nasal discharge, sneezing, throat discomfort, swelling of the uvula.
93 ohesion, hydration, and ciliary and airflow (sneeze) transportability.
94 tostatin [SST(+)]) mediates coughing but not sneezing, unraveling an unforeseen sensory difference be
95 es to catch expelled droplets from coughs or sneezes, use of face masks as appropriate, hand-washing
96 x responses, including expiration, coughing, sneezing, vomiting, postural control, production of spee
97 blocked nose, runny nose, nasal itching, and sneezing was used to evaluate symptoms.
98 erized by typical symptoms of nasal itching, sneezing, watery discharge and congestion.
99 inical signs, including fever, coughing, and sneezing, were present in both groups.
100 apidly increases by >/=150% in response to a sneeze, which is dependent on the release of adenosine t
101 tionally emphasized the role of coughing and sneezing, which are dramatic expiratory events that yiel
102 re involved in sinonasal ciliary response to sneezing, which is blunted in patients with upper-airway
103 RA) model for impulse emissions, coughing or sneezing, with aerosolized synthetic DNA tracer concentr
104 uses itching, nasal congestion, and repeated sneezing, with profound effects on quality of life, work
105  having nasal obstruction, secretion, and/or sneezing without having the common cold.
106                                     Sponges 'sneeze' without the benefit of nerves or muscles.

 
Page Top